Elanco Animal Health stock is trading -6.29% below its average target price of $23.82 after marking a 3.9% during today's afternoon session. Analysts are giving the Large-Cap Pharmaceutical company an average rating of buy and target prices ranging from $18.0 to $27.0 per share.
Elanco Animal Health has an average level of shares sold short, at 6.9% of its total share float. The stock's short ratio (also called days to cover) is 4.5. The company's insiders own 1.05% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Institutional investors own 111.0% of Elanco Animal Health's shares, which indicates they have a high level of confidence in the company.
Institutions Invested in Elanco Animal Health
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2025-06-30 | Dodge & Cox Inc | 17% | 82,895,232 | $1,850,221,552 |
| 2025-06-30 | FMR, LLC | 13% | 64,883,397 | $1,448,197,401 |
| 2025-06-30 | Primecap Management Company | 10% | 51,766,814 | $1,155,435,272 |
| 2025-09-30 | Vanguard Group Inc | 10% | 48,586,708 | $1,084,455,307 |
| 2025-06-30 | Blackrock Inc. | 5% | 23,071,471 | $514,955,225 |
| 2025-06-30 | Dimensional Fund Advisors LP | 5% | 22,746,400 | $507,699,641 |
| 2025-06-30 | T. Rowe Price Investment Management, Inc. | 4% | 19,554,942 | $436,466,299 |
| 2025-06-30 | Black Creek Investment Management Inc. | 4% | 19,250,840 | $429,678,742 |
| 2025-06-30 | Citadel Advisors Llc | 3% | 13,700,781 | $305,801,427 |
| 2025-06-30 | UBS Group AG | 2% | 10,506,691 | $234,509,339 |
